Novo Nordisk may be reorganizing its early-stage R&D capabilities, but the Danish pharma’s chief scientific officer has ...

In biopharmaceutical development, clinical trials generate vast amounts of data from various experimental sources and methods ...

The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...

India aims for Rs 17,000 crore investment in pharma R&D by FY28 through PRIP scheme, focusing on innovation and growth.

Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...

PRIP aims to transform India into a global powerhouse for R&D in the pharma and MedTech sector, with a total financial outlay of ₹5,000 crore – made up of two components. The first component ...

Tata Motors leads Nifty 100 companies in R&D spending, focusing on mobility solutions and alternative fuel technologies.

The Philippine Economic Zone Authority (PEZA) said over the weekend it released the guidelines for the registration of ...

This marks Jacobio's successful transformation from the early R&D stage to an innovation-driven value realization stage," said Dr.Yinxiang Wang, the Chairman and CEO of Jacobio Pharma. "Looking ahead ...

R&amp,D outsourcing involves pharmaceutical companies subcontracting parts of their R&amp,D efforts to third-party service providers. Small or mid-sized pharmaceutical or biotech houses may use ...

Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...